Skip to main content

ORIGINAL RESEARCH article

Front. Oncol. , 30 April 2020

Sec. Cancer Genetics

Volume 10 - 2020 | https://doi.org/10.3389/fonc.2020.00441

RETRACTED: Exosomal MicroRNA-221-3p Confers Adriamycin Resistance in Breast Cancer Cells by Targeting PIK3R1

Retracted

A retraction of this article was approved in:

  1. Retraction: Exosomal MicroRNA-221-3p Confers Adriamycin Resistance in Breast Cancer Cells by Targeting PIK3R1

    1. Read retraction
\r\nXiaoping Pan Xiaoping Pan1*Xiaolv HongXiaolv Hong2Jinguo LaiJinguo Lai1Lu ChengLu Cheng1Yandong ChengYandong Cheng3Mingmei YaoMingmei Yao1Rong WangRong Wang1Na HuNa Hu1
  • 1Clinical Laboratory, Huadu Hospital, Southern Medical University, Guangzhou, China
  • 2Department of Infectious Diseases, Huadu Hospital, Southern Medical University, Guangzhou, China
  • 3Department of Breast Surgery, Huadu Hospital, Southern Medical University, Guangzhou, China

This article has been retracted. Please follow the link to the full retraction notice for details.

Citation: Pan X, Hong X, Lai J, Cheng L, Cheng Y, Yao M, Wang R and Hu N (2020) Exosomal MicroRNA-221-3p Confers Adriamycin Resistance in Breast Cancer Cells by Targeting PIK3R1. Front. Oncol. 10:441. doi: 10.3389/fonc.2020.00441

Received: 12 December 2019; Accepted: 12 March 2020;
Published: 30 April 2020; Retracted: 30 December 2021.

Edited by:

Xiao Zhu, Guangdong Medical University, China

Reviewed by:

Fengchao Lang, University of Pennsylvania, United States
Chen Li, Charité—Universitätsmedizin Berlin, Germany

Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.

Research integrity at Frontiers

Man ultramarathon runner in the mountains he trains at sunset

94% of researchers rate our articles as excellent or good

Learn more about the work of our research integrity team to safeguard the quality of each article we publish.


Find out more